Anti-bacterial compositions

A kind of composition, technology of antibacterial agent, applied in the field of antibacterial composition, can solve the problem to be determined etc.

Inactive Publication Date: 2011-04-27
NOVARTIS AG
View PDF14 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Unlike Nod2, Nod1 is not related to Grim19 (Barnich N et al., 2005), suggesting that t

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anti-bacterial compositions
  • Anti-bacterial compositions
  • Anti-bacterial compositions

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0058]According to the present invention there is thus provided an isolated protein comprising multiple LRR (leucine rich repeat) domains for use as an antimicrobial agent. In use of the present invention such as described below, these proteins have been found to be effective in killing a wide variety of bacteria with potency comparable to known antibiotics.

[0059] In a preferred embodiment of the invention there are LRRs at the C-terminus of the protein. This has been found to increase the antimicrobial activity of the protein.

[0060] Further preferably, each LRR domain independently comprises or essentially consists of an amino acid sequence of formula (I):

[0061] (F1LxxLxL(xxZ) Y F2) (I)

[0062] in:

[0063] F1 and F2 are independently contiguous amino acid sequences of 1 to 30 residues;

[0064] x can be any amino acid;

[0065] L can be Leu, Ile, Val or Phe;

[0066] Z can be NxL or CxxL;

[0067] N is Asn, Thr, Ser or Cys;

[0068] C is Cys or Ser; and

...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

An isolated protein for use as an antimicrobial agent comprises a plurality of LRR (leucine rich repeat) domains, each LRR domain independently comprising an amino acid sequence of formula (I): (F1LxxLxL(xxZ)YF2) wherein: F1 and F2 are independently, a contiguous amino acid sequence of between 1 and 30 residues; x can be any amino acid; L can be Leu, Ile, VaI or Phe; Z can be NxL or CxxL; N is Asn, Thr, Ser or Cys; C is Cys or Ser; and Y = 0 or 1.

Description

1. Field of invention [0001] The present invention relates to antibacterial compositions and methods for treating or preventing pathogenic bacterial infections. More specifically, the present invention relates to antibacterial pharmaceutical compositions useful in the treatment or prevention of bacterial infections and diseases associated therewith. Other aspects, objects and advantages of the invention will be apparent from the following description. 2. Background of the invention [0002] The intestinal epithelium encloses bacteria in the gut lumen, allowing the host to harvest prokaryotic metabolites that it cannot synthesize itself, while protecting the host from infection. Because epithelial cells are frequently exposed to the microbiota of the gastrointestinal tract, they are also a major entry point for many pathogens. To protect against host infection, epithelial cells express various pattern recognition receptors (PRRs) such as Nod2 to provide the first line of de...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07K7/00C07K14/435A61K38/00A61P31/04
CPCA61K38/00C07K14/435A61P1/00A61P31/00A61P31/04Y02A50/30
Inventor S·帕金森L-H·佩雷兹
Owner NOVARTIS AG
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap